ArticleAdvances in neural information processing systems2025
STARC-9: A Large-scale Dataset for Multi-Class Tissue Classification for CRC Histopathology.
Article in Advances in neural information processing systems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
Abstract
Multi-class tissue-type classification of colorectal cancer (CRC) histopathologic images is a significant step in the development of downstream machine learning models for diagnosis and treatment planning. However, publicly available CRC datasets used to build tissue classifiers often suffer from insufficient morphologic diversity, class imbalance, and low-quality image tiles, limiting downstream model performance and generalizability. To address this research gap, we introduce STARC-9 (STAnford coloRectal Cancer), a large-scale dataset for multi-class tissue classification. STARC-9 comprises 630,000 histopathologic image tiles uniformly sampled across nine clinically relevant tissue classes (each represented by 70,000 tiles), systematically extracted from hematoxylin & eosin-stained whole-slide images (WSI) from 200 CRC patients at the Stanford University School of Medicine. To construct STARC-9, we propose a novel framework, DeepCluster++, consisting of two primary steps to ensure diversity within each tissue class, followed by pathologist verification. First, an encoder from an autoencoder trained specifically on histopathologic images is used to extract feature vectors from all tiles within a given input WSI. Next, K-means clustering groups morphologically similar tiles, followed by an equal-frequency binning method to sample diverse patterns within each tissue class. Finally, the selected tiles are verified by expert gastrointestinal pathologists to ensure classification accuracy. This semi-automated approach significantly reduces the manual effort required for dataset curation while producing high-quality training examples. To validate the utility of STARC-9, we benchmarked baseline convolutional neural networks, transformers, and pathology-specific foundation models on downstream multi-class CRC tissue classification and segmentation tasks when trained on STARC-9 versus publicly available datasets, demonstrating superior generalizability of models trained on STARC-9. Although we demonstrate the utility of DeepCluster++ on CRC as a pilot use-case, it is a flexible framework that can be used for constructing high-quality datasets from large WSI repositories across a wide range of cancer and non-cancer applications. https://huggingface.co/datasets/Path2AI/STARC-9/tree/main https://github.com/Path2AI/STARC-9/.
Identifiers
42088645PMC13138521What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.